<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>GARAMYCIN - gentamicin sulfate solution/ drops </strong><br>Fera Pharmaceuticals, LLC<br></p></div>
<h1></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>DESCRIPTION:</h1>
<p class="First"><br>Gentamicin sulfate is a water soluble antibiotic of the aminoglycoside group.</p>
<p>Gentamicin Sulfate Ophthalmic Solution is a sterile, aqueous solution buffered with dibasic sodium phosphate and monobasic sodium phosphate to approximately pH 7 (pH range 6.5 - 7.5) for ophthalmic use.  Each mL contains gentamicin sulfate, USP (equivalent to 3 mg gentamicin base), sodium chloride and benzalkonium chloride (0.1 mg) as a preservative.</p>
<p>Gentamicin is obtained from cultures of <span class="Italics">Micromonospora purpurea</span>.  It is a mixture of the sulfate salts of gentamicin C<span class="Sub">1</span>, C<span class="Sub">2</span> and C<span class="Sub">1A</span>.  All three components appear to have similar antimicrobial activities.  Gentamicin sulfate occurs as a white powder and is soluble in water and insoluble in alcohol.  The structure is as follows:</p>
<br><div class="Figure"><img alt="Garamycin Ophthalmic Solution Structural Formula" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aa2b006d-f67c-4c71-abce-55d55295b5bb&amp;name=a5471dfb-05ab-4e26-acb0-c244d0f932a7-01.jpg"></div>
<br><p></p>
<p></p>
<p></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY:</h1>
<p class="First"><span class="Bold">Microbiology:</span>  Gentamicin sulfate is active <span class="Italics">in vitro</span> against many <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the following microorganisms:</p>
<p><span class="Italics">Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, </span>and<span class="Italics"> Serratia marcescens.</span></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE:</h1>
<p class="First">Garamycin<span class="Sup">®</span> Ophthalmic Solution is indicated in the topical treatment of ocular <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">bacterial infections</span>, including <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratitis</span>, <span class="product-label-link" type="condition" conceptid="374035" conceptname="Keratitis">keratoconjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="373202" conceptname="Corneal ulcer">corneal ulcers</span>, <span class="product-label-link" type="condition" conceptid="378425" conceptname="Blepharitis">blepharitis</span>, <span class="product-label-link" type="condition" conceptid="374347" conceptname="Blepharoconjunctivitis">blepharoconjunctivitis</span>, acute <span class="product-label-link" type="condition" conceptid="4146941" conceptname="Meibomianitis">meibomianitis</span>, and dacryocystitis caused by susceptible <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of the following microorganisms:</p>
<p><span class="Italics">Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, </span>and<span class="Italics"> Serratia marcescens.</span></p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS:</h1>
<p class="First">Garamycin<span class="Sup">®</span> Ophthalmic Solution is contraindicated in patients with known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the components.<br></p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>WARNINGS:</h1>
<p class="First"><span class="Bold">NOT FOR INJECTION INTO THE EYE.</span>  Gentamicin Sulfate Ophthalmic Solution is not for injection.  It should never be injected subconjunctivally, nor should it be directly introduced into the anterior chamber of the eye.<br></p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First"><br></p>
<div class="Section" data-sectionCode="34072-9">
<a name="section-6.1"></a><p></p>
<h2>General:</h2>
<p class="First">Prolonged use of topical antibiotics may give rise to overgrowth of non-susceptible organisms including fungi.  <span class="product-label-link" type="condition" conceptid="4207042" conceptname="Viral resistance">Bacterial resistance</span> to gentamicin may also develop.  If <span class="product-label-link" type="condition" conceptid="4145093" conceptname="Purulent discharge">purulent discharge</span>, <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span> or <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span> becomes aggravated, the patient should discontinue use of the medication and consult a physician.</p>
<p>If irritation or <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any component of the drug develops, the patient should discontinue use of this preparation, and appropriate therapy should be instituted.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-6.2"></a><p></p>
<h2>Information For Patients:</h2>
<p class="First">To avoid contamination, do not touch tip of container to the eye, eyelid, or any surface.<br></p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-6.3"></a><p></p>
<h2>Carcinogenesis, Mutagenesis and Impairment of Fertility:</h2>
<p class="First">There are no published carcinogenicity or impairment of fertility studies on gentamicin.  Aminoglycoside antibiotics have been found to be non-mutagenic.<br></p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-6.4"></a><p></p>
<h2>Pregnancy:</h2>
<p class="First"><span class="Bold"><span class="Underline">Pregnancy Category C:</span></span>  Gentamicin has been shown to depress body weights, kidney weights, and median glomerular counts in newborn rats when administered systemically to pregnant rats in daily doses approximately 500 times the maximum recommended ophthalmic human dose.  There are no adequate and well-controlled studies in pregnant women.  Gentamicin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.<br></p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-6.5"></a><p></p>
<h2>Pediatric Use:</h2>
<p class="First">Safety and effectiveness in neonates have not been established.<br></p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS:</h1>
<p class="First">Bacterial and fungal <span class="product-label-link" type="condition" conceptid="373202" conceptname="Corneal ulcer">corneal ulcers</span> have developed during treatment with gentamicin ophthalmic preparations.</p>
<p>The most frequently reported adverse reactions are ocular burning and irritation upon drug instillation, non-specific <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>, conjunctival epithelial defects, and <span class="product-label-link" type="condition" conceptid="377283" conceptname="Conjunctival hyperemia">conjunctival hyperemia</span>.</p>
<p>Other adverse reactions which have occurred rarely are <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>, <span class="product-label-link" type="condition" conceptid="4119134" conceptname="Thrombocytopenic purpura">thrombocytopenic purpura</span>, and <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>.</p>
<p><span class="Italics">To report SUSPECTED ADVERSE REACTIONS, contact Fera Pharmaceuticals, LLC at (414) 434-6604, Monday-Friday 9am-5pm EST, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch</span>.<br></p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION:</h1>
<br>Instill one or two drops into the affected eye(s) every four hours.  In severe <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>, dosage may be increased to as much as two drops once per hour.<br>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-9"></a><p></p>
<h1>HOW SUPPLIED:</h1>
<p class="First">Garamycin<span class="Sup">®</span> Ophthalmic Solution, 0.3% is a sterile solution supplied in a plactic dropper bottle, box of one.</p>
<p>NDC 48102-022-05                       5mL Bottle</p>
<p>Store at 20<span class="Sup">o</span>-25<span class="Sup">o</span>C (68<span class="Sup">o</span>-77<span class="Sup">o</span>F) [See USP Controlled room temperature].</p>
<p>GARAMYCIN<span class="Sup">®</span> is a Registered Trademark of Fera Pharmaceuticals, LLC.</p>
<p></p>
<p>FERA<br></p>
<p>Mfd. for:</p>
<p>Fera Pharmaceuticals, LLC</p>
<p>Locust Valley, NY  11560</p>
<p>PF022A</p>
<p>R0411<br></p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-10"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - CARTON</h1>
<br><br><br><div class="Figure"><img alt="Garamycin Ophthalmic Solution Carton Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aa2b006d-f67c-4c71-abce-55d55295b5bb&amp;name=a5471dfb-05ab-4e26-acb0-c244d0f932a7-02.jpg"></div>
<br><br><br><br>FERA<br><br>NDC 48102-022-05<p class="First">STERILE        Rx only</p>
<p>Garamycin<span class="Sup">®</span><span class="Sup"></span></p>
<p>gentamicin sulfate</p>
<p>Ophthalmic</p>
<p>Solution, USP, 0.3%<br></p>
<p><br></p>
<p>(equivalent to 3 mg</p>gentamicin base per mL)<br><br><br>FOR OPHTHALMIC USE ONLY<br><br>5mL<br><br>CF02202A<br>R0311<br>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-11"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - BOTTLE</h1>
<br><div class="Figure"><img alt="Garamycin Ophthalmic Solution Bottle Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=aa2b006d-f67c-4c71-abce-55d55295b5bb&amp;name=a5471dfb-05ab-4e26-acb0-c244d0f932a7-03.jpg"></div>
<br>FERA<br><br><span class="Bold">NDC</span> 48102-022-05<br><br>Garamycin<span class="Sup">®</span><br><br><span class="Bold">gentamicin sulfate</span><br><br>Opthalmic Solution USP, 0.3%<br><br>(equivalent to 3 mg gentamicin base per mL)<br><br><span class="Bold">FOR OPHTHALMIC USE ONLY</span><br><br><span class="Bold">Sterile   5mL   Rx only</span><br>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>GARAMYCIN 		
					</strong><br><span class="contentTableReg">gentamicin sulfate solution/ drops</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:48102-022</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">OPHTHALMIC</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>GENTAMICIN SULFATE</strong> (GENTAMICIN) </td>
<td class="formItem">GENTAMICIN</td>
<td class="formItem">3 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZALKONIUM CHLORIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM CHLORIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM PHOSPHATE, DIBASIC</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM PHOSPHATE, MONOBASIC</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:48102-022-05</td>
<td class="formItem">1  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">5 mL in 1 BOTTLE, DROPPER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA065121</td>
<td class="formItem">05/15/2011</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Fera Pharmaceuticals, LLC
							(831023713)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Fera Pharmaceuticals, LLC (831023713)</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 4/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>a5471dfb-05ab-4e26-acb0-c244d0f932a7</div>
<div>Set id: aa2b006d-f67c-4c71-abce-55d55295b5bb</div>
<div>Version: 1</div>
<div>Effective Time: 20110426</div>
</div>
</div> <div class="DistributorName">Fera Pharmaceuticals, LLC</div></p>
</body></html>
